Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PANACEA LIFE SCIENCES HOLDINGS, INC.PLSH · Entity 9699 | Director · CEO · 10% owner | September 18, 2023 | September 20, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PANACEA LIFE SCIENCES HOLDINGS, INC.
Report date September 18, 2023 · Filed September 20, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,533,949 |
Reported balance
After 2023-09-18 transaction · row 1
1 source rowRow 1 · 2023-09-18 · Purchase · Acquired 20,000 · Balance 1,533,949 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2022 Filed Jan 30, 2023 11:10 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 500 | $0.13 | $63.00 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 12 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 668,049 Read SEC document |
| June 14, 2022 Filed Jan 30, 2023 11:10 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 500 | $0.18 | $91.05 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 11 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,549 Read SEC document |
| June 06, 2022 Filed Jan 30, 2023 11:10 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 300 | $0.43 | $127.53 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 10 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,049 Read SEC document |
| May 23, 2022 Filed Jan 30, 2023 11:10 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 100 | $0.50 | $50.00 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 9 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,749 Read SEC document |
| May 17, 2022 Filed Jan 30, 2023 11:10 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 100 | $0.50 | $49.99 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 8 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,649 Read SEC document |
| May 16, 2022 Filed Jan 30, 2023 11:10 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 200 | $0.42 | $83.18 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 7 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,549 Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 20:08 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 1,050 | $0.48 | $507.05 |
DisclosureSEC source: 0001493152-22-009276 · ownership.xml · nonDerivative · entry 5 Buttorff Leslie · CIK 0001866792 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 619,449 Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 20:08 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 1,404 | $0.60 | $842.40 |
DisclosureSEC source: 0001493152-22-009276 · ownership.xml · nonDerivative · entry 4 Buttorff Leslie · CIK 0001866792 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618,399 Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 20:08 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 4,096 | $0.45 | $1,843.20 |
DisclosureSEC source: 0001493152-22-009276 · ownership.xml · nonDerivative · entry 3 Buttorff Leslie · CIK 0001866792 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 616,995 Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 20:08 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 500 | $0.59 | $295.00 |
DisclosureSEC source: 0001493152-22-009276 · ownership.xml · nonDerivative · entry 2 Buttorff Leslie · CIK 0001866792 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612,899 Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 20:08 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 11,000 | $0.50 | $5,500.00 |
DisclosureSEC source: 0001493152-22-009276 · ownership.xml · nonDerivative · entry 1 Buttorff Leslie · CIK 0001866792 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612,399 Read SEC document |
| February 16, 2022 Filed Jan 30, 2023 11:10 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 100 | $0.70 | $69.80 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 6 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,349 Read SEC document |
| February 11, 2022 Filed Jan 30, 2023 11:10 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 200 | $0.69 | $137.60 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 5 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,249 Read SEC document |
| January 25, 2022 Filed Jan 30, 2023 11:10 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 700 | $0.85 | $594.93 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 4 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,049 Read SEC document |
| January 20, 2022 Filed Jan 30, 2023 11:10 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 2,300 | $0.66 | $1,506.50 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 3 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 665,349 Read SEC document |
| January 19, 2022 Filed Jan 30, 2023 11:10 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 1,000 | $0.71 | $710.00 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 2 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 663,049 Read SEC document |
| January 18, 2022 Filed Jan 30, 2023 11:10 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 1,100 | $0.71 | $784.30 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 1 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 662,049 Read SEC document |
| December 21, 2021 Filed Feb 14, 2022 23:36 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 1,000 | $0.90 | $902.40 |
DisclosureSEC source: 0001493152-22-004599 · ownership.xml · nonDerivative · entry 2 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601,399 Read SEC document |
| December 21, 2021 Filed Feb 14, 2022 23:36 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | PurchaseCommon Stock | 500 | $1.00 | $499.90 |
DisclosureSEC source: 0001493152-22-004599 · ownership.xml · nonDerivative · entry 1 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,399 Read SEC document |
| October 25, 2021 Filed Feb 14, 2022 23:36 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | GrantSeries C-2 Preferred Stock | 100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-22-004599 · ownership.xml · nonDerivative · entry 6 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Quintel-MC, Incorporated Disclosed balance after: 100 F2 · security: The Series C-2 designates 100 shares for issuance, par value $0.0001 per share. Each share of Series C-2 is convertible into 73,215 shares of the Company's common stock and is entitled to vote on all matters submitted to the Company's stockholders on an as-converted basis. Other than the conversion and voting rights, there are no other preferences. F3 · price: The shares of preferred stock were acquired in connection with the cancellation of 7,321,429 shares of the Company's common stock that were held by Quintel-MC, Incorporated. Read SEC document |
| October 25, 2021 Filed Feb 14, 2022 23:36 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH · Entity 9699 | Disposition to issuerCommon Stock | 7,321,429 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-22-004599 · ownership.xml · nonDerivative · entry 3 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Quintel-MC, Incorporated Disclosed balance after: 4,047,054 F1 · price: The shares of common stock were cancelled in connection with the designation of 100 shares of Series C-2 Convertible Preferred Stock to Quintel-MC, Incorporated. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:05 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. EXDI · Entity 9699 | GrantSeries D Preferred Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-003386 · form4-07022021_040701.xml · nonDerivative · entry 5 Buttorff Leslie · CIK 0001866792 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by J&N Real Estate Company LLC Disclosed balance after: 10,000 F2 · price: The shares of preferred stock were acquired in exchange for shares of preferred stock of Panacea, in connection with the Exchange Agreement. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:05 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. EXDI · Entity 9699 | GrantSeries C-1 Preferred Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-003386 · form4-07022021_040701.xml · nonDerivative · entry 4 Buttorff Leslie · CIK 0001866792 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Quintel-MC, Incorporated Disclosed balance after: 10,000 F2 · price: The shares of preferred stock were acquired in exchange for shares of preferred stock of Panacea, in connection with the Exchange Agreement. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:05 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. EXDI · Entity 9699 | GrantSeries C Preferred Stock | 1,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-003386 · form4-07022021_040701.xml · nonDerivative · entry 3 Buttorff Leslie · CIK 0001866792 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Quintel-MC, Incorporated Disclosed balance after: 1,000,000 F2 · price: The shares of preferred stock were acquired in exchange for shares of preferred stock of Panacea, in connection with the Exchange Agreement. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:05 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. EXDI · Entity 9699 | GrantCommon Stock | 318,317,499 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-003386 · form4-07022021_040701.xml · nonDerivative · entry 2 Buttorff Leslie · CIK 0001866792 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Quintel-MC, Incorporated Disclosed balance after: 318,317,499 F1 · price: The shares of common stock were acquired in exchange for shares of common stock of Panacea Life Sciences, Inc. ("Panacea"), in connection with the Securities Exchange Agreement dated June 30, 2021 between the Issuer, Panacea and the shareholders of Panacea (the "Exchange Agreement"). Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:05 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. EXDI · Entity 9699 | GrantCommon Stock | 16,797,145 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-003386 · form4-07022021_040701.xml · nonDerivative · entry 1 Buttorff Leslie · CIK 0001866792 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,797,145 F1 · price: The shares of common stock were acquired in exchange for shares of common stock of Panacea Life Sciences, Inc. ("Panacea"), in connection with the Securities Exchange Agreement dated June 30, 2021 between the Issuer, Panacea and the shareholders of Panacea (the "Exchange Agreement"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.